Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis
- PMID: 22220193
- PMCID: PMC3248405
- DOI: 10.1371/journal.pone.0028691
Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis
Abstract
Background: We systematically reviewed observational studies of early mortality post-antiretroviral therapy (ART) initiation in low- and middle-income countries (LMIC) in Asia, Africa, and Central and South America, as defined by the World Bank, to summarize what is known.
Methods and findings: Studies published in English between January 1996 and December 2010 were searched in Medline and EMBASE. Three independent reviewers examined studies of mortality within one year post-ART. An article was included if the study was conducted in a LMIC, participants were initiating ART in a non-clinical trial setting and were ≥15 years. Fifty studies were included; 38 (76%) from sub-Saharan Africa (SSA), 5 (10%) from Asia, 2 (4%) from the Americas, and 5 (10%) were multi-regional. Median follow-up time and pre-ART CD4 cell count ranged from 3-55 months and 11-192 cells/mm(3), respectively. Loss-to-follow-up, reported in 40 (80%) studies, ranged from 0.3%-27%. Overall, SSA had the highest pooled 12-month mortality probability of 0.17 (95% CI 0.11-0.24) versus 0.11 (95% CI 0.10-0.13) for Asia, and 0.07 (95% CI 0.007-0.20) for the Americas. Of 14 (28%) studies reporting cause-specific mortality, tuberculosis (TB) (5%-44%), wasting (5%-53%), advanced HIV (20%-37%), and chronic diarrhea (10%-25%) were most common. Independent factors associated with early mortality in 30 (60%) studies included: low baseline CD4 cell count, male sex, advanced World Health Organization clinical stage, low body mass index, anemia, age greater than 40 years, and pre-ART quantitative HIV RNA.
Conclusions: Significant heterogeneity in outcomes and in methods of reporting outcomes exist among published studies evaluating mortality in the first year after ART initiation in LMIC. Early mortality rates are highest in SSA, and opportunistic illnesses such as TB and wasting syndrome are the most common reported causes of death. Strategies addressing modifiable risk factors associated with early death are urgently needed.
Conflict of interest statement
Figures




Similar articles
-
Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis.Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD009012. doi: 10.1002/14651858.CD009012.pub3. Cochrane Database Syst Rev. 2018. PMID: 30039850 Free PMC article.
-
Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age.Cochrane Database Syst Rev. 2012 Jul 11;(7):CD004772. doi: 10.1002/14651858.CD004772.pub3. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2014 May 22;(5):CD004772. doi: 10.1002/14651858.CD004772.pub4. PMID: 22786492 Updated.
-
Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.Cochrane Database Syst Rev. 2010 Apr 14;(4):CD008494. doi: 10.1002/14651858.CD008494. Cochrane Database Syst Rev. 2010. PMID: 20393969
-
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2. Cochrane Database Syst Rev. 2020. PMID: 33075160 Free PMC article.
-
Antidepressants for depression in adults with HIV infection.Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD008525. doi: 10.1002/14651858.CD008525.pub3. Cochrane Database Syst Rev. 2018. PMID: 29355886 Free PMC article.
Cited by
-
Timing, rates, and causes of death in a large South African tuberculosis programme.BMC Infect Dis. 2014 Dec 21;14:3858. doi: 10.1186/s12879-014-0679-9. BMC Infect Dis. 2014. PMID: 25528248 Free PMC article.
-
Cost of Providing Advanced HIV Disease Treatment Services through Malawi's Hub-and-Spoke Model.Am J Trop Med Hyg. 2024 Aug 20;111(4):897-903. doi: 10.4269/ajtmh.23-0880. Print 2024 Oct 2. Am J Trop Med Hyg. 2024. PMID: 39163852
-
Adherence, Effectiveness and Safety of Dolutegravir Based Antiretroviral Regimens among HIV Infected Children and Adolescents in Tanzania.J Int Assoc Provid AIDS Care. 2022 Jan-Dec;21:23259582221109613. doi: 10.1177/23259582221109613. J Int Assoc Provid AIDS Care. 2022. PMID: 35776522 Free PMC article.
-
Survival and associated factors among people living with HIV/AIDS: A 30-year national survey in Iran.J Res Med Sci. 2019 Jan 31;24:5. doi: 10.4103/jrms.JRMS_630_18. eCollection 2019. J Res Med Sci. 2019. PMID: 30815018 Free PMC article.
-
Effects on anthropometry and appetite of vitamins and minerals given in lipid nutritional supplements for malnourished HIV-infected adults referred for antiretroviral therapy: results from the NUSTART randomized controlled trial.J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):405-12. doi: 10.1097/QAI.0000000000000483. J Acquir Immune Defic Syndr. 2015. PMID: 25501607 Free PMC article. Clinical Trial.
References
-
- Joint United Nations Programme on HIV and AIDS (UNAIDS) Financial Resources Required to Achieve, Universal Access to HIV Prevention, Treatment Care and Support. 2007. Available: http://data.unaids.org/pub/Report/2007/JC1678_Fin_Res_Req_en.pdf.
-
- Palella FJ, Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853–860. - PubMed
-
- Severe P, Leger P, Charles M, Noel F, Bonhomme G, et al. Antiretroviral therapy in a thousand patients with AIDS in Haiti. N Engl J Med. 2005;353:2325–2334. - PubMed
-
- Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA. 2006;296:782–793. - PubMed
-
- Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;367:817–824. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials